Overview Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 Status: Completed Trial end date: 2004-01-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare Symbicort with budesonide alone and with formoterol alone in the treatment of asthma in adolescents and adults Phase: Phase 3 Details Lead Sponsor: AstraZenecaTreatments: BudesonideBudesonide, Formoterol Fumarate Drug CombinationFormoterol Fumarate